SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-019899
Filing Date
2023-07-13
Accepted
2023-07-13 17:26:07
Documents
13
Period of Report
2023-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230713_8k.htm   iXBRL 8-K 49938
  Complete submission text file 0001437749-23-019899.txt   170284

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arch-20230707.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230707_def.xml EX-101.DEF 9653
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230707_lab.xml EX-101.LAB 12884
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230707_pre.xml EX-101.PRE 9538
7 EXTRACTED XBRL INSTANCE DOCUMENT arch20230713_8k_htm.xml XML 2177
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 231087512
SIC: 3841 Surgical & Medical Instruments & Apparatus